{"id":3586,"date":"2025-04-08T15:29:57","date_gmt":"2025-04-08T12:29:57","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=3586"},"modified":"2025-04-08T15:29:58","modified_gmt":"2025-04-08T12:29:58","slug":"new-drug-submission-for-agamree-vamorolone-accepted-for-priority-review-by-health-canada-for-the-treatment-of-duchenne-muscular-dystrophy","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/zh\/new-drug-submission-for-agamree-vamorolone-accepted-for-priority-review-by-health-canada-for-the-treatment-of-duchenne-muscular-dystrophy\/","title":{"rendered":"\u52a0\u62ff\u5927\u536b\u751f\u90e8\u63a5\u53d7 AGAMREE\uff08vamorolone\uff09\u65b0\u836f\u7533\u8bf7\uff0c\u7528\u4e8e\u6cbb\u7597\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Catalyst Pharmaceuticals \u5ba3\u5e03\uff0c\u52a0\u62ff\u5927\u536b\u751f\u90e8\u5df2\u63a5\u53d7\u5176 AGAMREE\uff08vamorolone\uff09\u7684\u65b0\u836f\u7533\u8bf7 (NDS)\uff0c\u8be5\u836f\u7269\u7528\u4e8e\u6cbb\u7597\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7 (DMD)\uff0c\u5e76\u88ab\u5217\u4e3a\u4f18\u5148\u5ba1\u67e5\u836f\u7269\u3002\u5982\u679c\u83b7\u5f97\u6279\u51c6\uff0cAGAMREE \u5c06\u6210\u4e3a\u52a0\u62ff\u5927\u536b\u751f\u90e8\u6279\u51c6\u7684\u9996\u4e2a\u4e5f\u662f\u552f\u4e00\u4e00\u4e2a DMD \u6cbb\u7597\u836f\u7269\uff0c\u5e76\u6709\u671b\u4e8e 2025 \u5e74\u5e95\u83b7\u5f97\u4e0a\u5e02\u8bb8\u53ef\u3002<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u6b64\u6b21\u63d0\u4ea4\u662f\u7ee7 AGAMREE \u5728\u7f8e\u56fd\uff082023 \u5e74\uff09\u548c\u6b27\u76df\uff082024 \u5e74\u521d\uff09\u83b7\u5f97\u6279\u51c6\u4e4b\u540e\u7684\u53c8\u4e00\u4e3e\u63aa\u3002\u6839\u636e\u52a0\u62ff\u5927\u795e\u7ecf\u808c\u8089\u75be\u75c5\u767b\u8bb0\u5904\u7684\u6570\u636e\uff0c\u52a0\u62ff\u5927\u6709 800 \u591a\u540d\u7537\u5b69\u548c\u5e74\u8f7b\u7537\u6027\u60a3\u6709 DMD\uff0c\u8fd9\u662f\u4e00\u79cd\u7f55\u89c1\u75be\u75c5\uff0c\u7531\u4e8e\u7f3a\u4e4f\u808c\u8425\u517b\u4e0d\u826f\u86cb\u767d\u800c\u5bfc\u81f4\u808c\u8089\u65e0\u529b\u3002\uff08<a href=\"https:\/\/dmdwarrior.com\/zh\/what-is-agamree-vamorolone-what-is-agamree-used-for\/\" target=\"_blank\" data-type=\"post\" data-id=\"2333\" rel=\"noreferrer noopener\">\u4ec0\u4e48\u662f Agamree\uff1f<\/a>)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u8be5\u836f\u7269\u7684\u7814\u53d1\u5305\u62ec\u5728\u52a0\u62ff\u5927\u7684\u4e94\u4e2a\u5730\u70b9\u8fdb\u884c\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8fd9\u4e3a\u5176\u5728\u5168\u7403\u83b7\u5f97\u6279\u51c6\u505a\u51fa\u4e86\u8d21\u732e\u3002\u5305\u62ec\u52a0\u62ff\u5927\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u534f\u4f1a\u548c\u52a0\u62ff\u5927\u808c\u8089\u840e\u7f29\u75c7\u534f\u4f1a\u5728\u5185\u7684\u60a3\u8005\u7ec4\u7ec7\u5bf9\u8fd9\u4e00\u8fdb\u5c55\u8868\u793a\u6b22\u8fce\uff0c\u5e76\u5f3a\u8c03\u52a0\u62ff\u5927\u76ee\u524d\u7f3a\u4e4f\u83b7\u6279\u7684\u6cbb\u7597\u65b9\u6cd5\u3002<\/p>","protected":false},"excerpt":{"rendered":"<p>Catalyst Pharmaceuticals has announced that Health Canada has accepted their New Drug Submission (NDS) for AGAMREE (vamorolone) with priority review status for treating Duchenne muscular dystrophy (DMD). If approved, AGAMREE would become the first and only Health Canada-approved therapy for DMD, with potential marketing authorization by the end of 2025. The submission follows AGAMREE&#8217;s approvals [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3588,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[42,171,43],"class_list":["post-3586","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-agamree","tag-canada","tag-vamorolone"],"subtitle":"\u52a0\u62ff\u5927\u536b\u751f\u90e8\u5df2\u5bf9 AGAMREE \u7ed9\u4e88\u4f18\u5148\u5ba1\u67e5\uff0c\u4e14\u6709\u671b\u5728 2025 \u5e74\u5e95\u4e4b\u524d\u6388\u4e88\u8425\u9500\u6388\u6743\u3002","_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/posts\/3586","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/comments?post=3586"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/posts\/3586\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/media\/3588"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/media?parent=3586"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/categories?post=3586"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/tags?post=3586"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}